Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer

Regeneron Pharmaceuticals · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
smallcelllungcancer
advanced nsclc, non-small cell lung cancer, mesenchymal epithelial transition factor (met), met overexpressing advanced cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 917893
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.